IMNN

insider transactions

Imunon, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 5, 26

Michael H Tardugno KEY

Executive Chairman of Board

$8.4K

4.1K sh · $2.06

Own +47%
Grant·A
Jun 5, 26

Stacy Lindborg KEY

President and CEO

$3.3K

1.6K sh · $2.06

Own +44%
Grant·A
May 22, 26

Michael H Tardugno KEY

Executive Chairman of Board

$7.7K

3.5K sh · $2.20

Own +66%
Grant·A
May 22, 26

Christine A Pellizzari

Director

$12.2K

5.6K sh · $2.20

Own +215%
Grant·A
May 22, 26

Stacy Lindborg KEY

President and CEO

$3.3K

1.5K sh · $2.20

Own +69%
Grant·A
May 22, 26

Frederick J. Fritz

Director

$22.7K

10.3K sh · $2.20

Own +274%
Grant·A
May 22, 26

James E Dentzer

Director

$24.5K

11.1K sh · $2.20

Own +292%
Grant·A
May 22, 26

Donald P Braun

Director

$11.0K

5.0K sh · $2.20

Own +116%
Grant·A
Jan 2, 26

Christine A Pellizzari

Director

$0

4.8K sh

Own New
Grant·A
Jan 2, 26

Michael H Tardugno KEY

Executive Chairman of Board

$0

43.8K sh

Own New
Grant·A
Jan 2, 26

Stacy Lindborg KEY

President and CEO

$0

56.2K sh

Own New
Grant·A
Jan 2, 26

Frederick J. Fritz

Director

$0

5.9K sh

Own New
Grant·A
Jan 2, 26

Douglas Vincent Faller

Chief Medical Officer

$0

12.7K sh

Own New
Grant·A
Jan 2, 26

Susan Eylward

General Counsel and Corp Sec

$0

8.3K sh

Own New
Grant·A
Jan 2, 26

James E Dentzer

Director

$0

4.4K sh

Own New
Grant·A
Jan 2, 26

Donald P Braun

Director

$0

5.9K sh

Own New
Grant·A
Jan 2, 26

Kimberly Bragg KEY

CFO

$0

9.1K sh

Own New
Grant·A
Jan 2, 26

Khursheed Anwer

Chief Scientific Officer

$0

15.7K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 5, 2026	Michael H Tardugno KEY	Executive Chairman of Board	Grant A	4.1K	+47%	$2.06	$8.4K
Jun 5, 2026	Stacy Lindborg KEY	President and CEO	Grant A	1.6K	+44%	$2.06	$3.3K
May 22, 2026	Michael H Tardugno KEY	Executive Chairman of Board	Grant A	3.5K	+66%	$2.20	$7.7K
May 22, 2026	Christine A Pellizzari	Director	Grant A	5.6K	+215%	$2.20	$12.2K
May 22, 2026	Stacy Lindborg KEY	President and CEO	Grant A	1.5K	+69%	$2.20	$3.3K
May 22, 2026	Frederick J. Fritz	Director	Grant A	10.3K	+274%	$2.20	$22.7K
May 22, 2026	James E Dentzer	Director	Grant A	11.1K	+292%	$2.20	$24.5K
May 22, 2026	Donald P Braun	Director	Grant A	5.0K	+116%	$2.20	$11.0K
Jan 2, 2026	Christine A Pellizzari	Director	Grant A	4.8K	New	—	$0
Jan 2, 2026	Michael H Tardugno KEY	Executive Chairman of Board	Grant A	43.8K	New	—	$0
Jan 2, 2026	Stacy Lindborg KEY	President and CEO	Grant A	56.2K	New	—	$0
Jan 2, 2026	Frederick J. Fritz	Director	Grant A	5.9K	New	—	$0
Jan 2, 2026	Douglas Vincent Faller	Chief Medical Officer	Grant A	12.7K	New	—	$0
Jan 2, 2026	Susan Eylward	General Counsel and Corp Sec	Grant A	8.3K	New	—	$0
Jan 2, 2026	James E Dentzer	Director	Grant A	4.4K	New	—	$0
Jan 2, 2026	Donald P Braun	Director	Grant A	5.9K	New	—	$0
Jan 2, 2026	Kimberly Bragg KEY	CFO	Grant A	9.1K	New	—	$0
Jan 2, 2026	Khursheed Anwer	Chief Scientific Officer	Grant A	15.7K	New	—	$0

About IMNN insider trading

This page tracks insider transactions for Imunon, Inc. (IMNN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.